Prof. Dr. med. Hartmut Dohner
internal medicine, hematology, and oncology
internal medicine, hematology, and oncology
Overview
Country, City
Germany, Ulm
Health facility
University Hospital Ulm
Medical unit
Department of internal medicine (hematology, oncology, palliative medicine, rheumatology, and infectious diseases)
About the doctor
Skills & Expertise
leukemia
hematology
oncology
cancer
chemotherapy
transplantation
gemtuzumab
ozogamicin
tumor
elderly
myeloma
lymphoma
medulloblastoma
Resume
CV (Curriculum Vitae)
Education
- 1976-1977 Studied human medicine at the University of Regensburg Medical School, Regensburg
- 1977-1979 Studied human medicine at the University of Freiburg Medical School, Freiburg
- 1979-1980 Scholarship at the University of Montpellier Medical School, Montpellier
- 1980-1983 Studied human medicine at the University of Freiburg Medical School, Freiburg
- Obtaining a license for medical practice
- 1983-1985 Residency in surgical pathology, Institute of Pathology, St. Vincentius Hospital in Karlsruhe (Prof. H.M. Schneider, Dr. H. Wolfmuller)
- 1985 Defense of the dissertation at the University of Freiburg Medical School, Freiburg
- 1985-1988 Training in internal medicine, hematology, and oncology at the University of Heidelberg
- 1993 Obtaining specialization in internal medicine
- 1994 Habilitation at the University of Heidelberg Medical School
- 1998 Received additional qualifications in the field of hematology and oncology
- 1999 Professor of medicine at the University of Ulm
Experience
- 1988-1990 Postdoctoral Associate in the Department of medicine, division of oncology and the Department of laboratory medicine and pathology, division of medical genetics at the University of Minnesota
- 1990-1993 Training in internal medicine, hematology, and oncology at the University of Heidelberg
- 1993-1999 Senior Physician, Division of hematology, oncology and rheumatology at the University of Heidelberg
- 2003-2011 Director, Department of internal medicine (hematology, oncology, palliative medicine, rheumatology, and infectious diseases) at the University Hospital Ulm
- 1999 Medical Director, Department of internal medicine (hematology, oncology, palliative medicine, rheumatology, and infectious diseases) at the University Hospital Ulm
- 2006 Director at the Comprehensive Cancer Center Ulm
- 2014-2015 Vice President for medicine and diversity, Ulm University
- 2018-2020 Director, Department of internal medicine (hematology, oncology, palliative medicine, rheumatology, and infectious diseases) at the University Hospital Ulm
Awards & Memberships
- 1979-1980 Scholar of the German Academic Exchange Service
- 1988-1990 Research Scholar of the Mildred Scheel Foundation
- 1993 Member of the American Society of Hematology
- 1995 Leukemia Clinical Research Award of the German Society of Hematology and Oncology
- 1996 Member of the German Society of Hematology and Oncology
- 2001 Member of the European Hematology Association
- 2002 Member of the American Society of Clinical Oncology
- 2006 Member of the German Cancer Society
- 2009 Recipient of the Kenneth McCredie Lectureship at the International Association for Comparative Research on Leukemia and Related Disorders, Ohio
- 2010 Anita- and Cuno-Wieland Research Award for Translational Cancer Research, University of Heidelberg
- 2011 Wilhelm-Warner Award for Cancer Research in Hamburg
- 2012 Elected Member of the Berlin-Brandenburg Academy of Sciences and Humanities
- 2012 Coordinator at the Collaborative Research Center 1074: “Experimental models and clinical translation in leukemia”
- 2014 Jose Carreras Award of the European Hematology Association
- 2014 Clarivate Web of Science Highly Cited Researcher
- 2019 Medal of the Polish Society of Haematologists and Transfusiologists
- 2019 Binet-Rai Medal of the International Workshop of Chronic Lymphocytic Leukemia
- 2021 Johann Georg Zimmermann Medal
Languages
English
German
Publications
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
8 September, 2023
POSTER: AML-469 Ivosidenib + Azacitidine vs Placebo + Azacitidine in Patients With Newly-Diagnosed Acute Myeloid Leukemia: Updated Long-term Efficacy and Safety Results From the AGILE Study
1 September, 2023
All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results - Authors' reply.
1 September, 2023
Location
Albert-Einstein-Allee, 23, 89081 Ulm, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Hartmut Dohner?
The primary specialization of the doctor is internal medicine, hematology, and oncology.
What is the experience of the specialist?
Prof. Dr. med. Hartmut Dohner has been practicing for more than 41 years.
Prof. Dr. med. Hartmut Dohner
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Hartmut Dohner